Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Australian Pharmaceutical (ASX:API) share price sinks as Woolworths withdraws $1.75 bid

Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API). 

Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its non-binding proposal for Priceline owner Australian Pharmaceutical Industries Ltd (ASX: API).

Subsequently, the API share price has tumbled 12.43% in morning trade to $1.52.

Conversely, the Woolworths share price is largely unmoved.

Australia’s largest grocery chain reignited its longtime rivalry with former Coles owner Wesfarmers Ltd (ASX: WES) when it launched a surprising $1.75 per share offer for API in December.

Previously Wesfarmers had made and API had agreed to a $1.55 per share cash offer to acquire the pharmacy chain.

It also holds a 19.3% voting stake in the business, shielding its lower bid from other suitors such as Woolworths and Sigma Healthcare Ltd (ASX: SIG).

Bidding war: API (ASX: API) share price up on new Sigma (ASX:SIG) bid

Numbers didn’t stack up

Following the completion of due diligence, Woolworths noted that it was unable to confirm it could achieve a sufficient financial return within the company’s capital allocation framework.

Subsequently, it has withdrawn its offer.

Commenting on the decision, Woolworths CEO, Brad Banducci said:

“We are grateful to the Board and leadership team of API for their constructive engagement and support throughout the due diligence process.”

Wesfarmers deal on track

In response to Woolworth’s withdrawal, API said that its existing Scheme Implementation Deed (SID) with Wesfarmers remains in place and on track for the first quarter of 2022.

With the deal all but finalised, the Wesfarmers share price is up 2.00% to $59.24.

After reducing the 2 cents per share paid in December to API shareholders, Wesfarmers will acquire the remaining 80.7% share it does not own API for $1.53 per share.

My take

Woolworths announcement was short on details other than $1.75 per share price tag, or $872 million total bid, didn’t stack financially.

Perhaps Woolworths overreached with a bid of 20 cents per share higher than Wesfarmers?

Nonetheless, this battle looks largely complete with Wesfarmers SID to be completed within the next three months.

If you enjoyed this update, consider signing up for a free Rask account and accessing our full stock reports.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content